市場調查報告書
商品編碼
1384662
心血管資訊系統全球市場規模、佔有率和行業趨勢分析報告:2023-2030年依類型、營運模式和地區分類的展望和預測Global Cardiovascular Information System Market Size, Share & Industry Trends Analysis Report By Type (CVIS, and CPACS), By Mode Of Operation (Web-based, Cloud-based, and On-site), By Regional Outlook and Forecast, 2023 - 2030 |
心血管資訊系統市場規模預計到 2030 年將達到 22 億美元,預測期內市場成長率為 10.2%。
根據KBV Cardinal矩陣中發布的分析,思科系統公司和甲骨文公司是該市場的先驅。 2021 年 7 月,思科系統公司宣布收購Socio Labs, Inc.,加強 Cisco Webex 平台產品並為客戶提供更好的線上活動體驗。霍尼韋爾國際公司、麥克森公司和西門子醫療公司等公司是該市場的主要創新者。
COVID-19 影響分析
由於大流行,醫療機構面臨財務困難。許多資源被用於應對新冠肺炎 (COVID-19) 疫情,影響了其他醫療保健技術的資金投入。因此,一些醫療保健提供者推遲了對 CVIS 和其他非緊急系統的投資。大流行擾亂了醫療機構的正常業務。這推遲了包括車路協同在內的新技術的引入。因此,疫情對市場產生了較為正面的影響。 CVIS 的採用已成為醫療保健領域的關鍵因素,從而促使未來幾年市場的積極成長。
市場成長要素
提高效率並最佳化工作流程
對醫療保健效率的重視促使了 CVIS 系統的採用,該系統簡化了臨床工作流程、減輕了管理負擔並提高了患者照護的整體效率。市場透過提供專門的解決方案來滿足這一需求,這些解決方案可以自動執行與資料搜尋、測試解釋和報告生成相關的各種任務。這種最佳化透過實現快速診斷和治療來直接影響患者的治療結果,從而提高醫療保健提供者和患者的臨床效果和滿意度。資料驅動的醫學正在推動對先進 CVIS 解決方案的需求,這些解決方案可以有效地捕獲、儲存和管理大量患者資料和診斷資訊。因此,對能夠實現高效資料管理和工作流程最佳化的 CVIS 解決方案的需求不斷成長,這證實了這些系統在現代醫療保健服務中發揮關鍵作用。
擴大醫療基礎設施
人口的快速成長,特別是在都市區,增加了對醫療基礎設施的需求。需要擴大設施和服務,以適應越來越多的尋求醫療服務的患者。隨著世界人口高齡化,對解決與老齡化相關的健康問題並提供長期照護的醫療保健服務的需求日益成長。醫療基礎設施的擴張通常包括建立新的循環系統和循環系統護理設施。 CVIS 解決方案可協助這些部門提供一個全面的平台來有效管理病患資料和診斷資訊。醫療保健基礎設施的擴張正在創造對專業解決方案的需求,這些解決方案支持心血管患者資料和診斷資訊的有效管理,從而增強了市場的成長和重要性。
市場抑制因素
高實施成本和複雜性
與 CVIS 相關的高實施成本是許多醫療機構的主要障礙。這些成本包括硬體和軟體採購、客製化、與現有系統的整合以及全面的員工培訓。對於小型醫療機構和預算有限的機構來說,這些財務要求可能令人望而卻步,並成為 CVIS 實施的障礙。因此,許多醫療保健提供者無法利用 CVIS 提供的先進資料管理和診斷功能,導致醫療保健服務中出現數位落差。這些課題阻礙了市場擴張,並限制了 CVIS 在簡化資料管理、增強診斷能力和改善患者照護所能提供的潛在優勢。
依類型分類的展望
依類型分類,市場分為 CVIS 和 CPACS。 2022 年,CPACS 區隔市場在市場中佔了重要的收益佔有率。心血管影像存檔和通訊系統 (CPACS) 旨在管理心血管影像,例如超音波心動圖、血管造影術和核醫學掃描。 CPACS 提供了這些影像的安全儲存庫,使醫療保健專業人員可以輕鬆存取它們。 CPACS 確保心血管影像的品質和一致性,包括影像格式、解析度和壓縮,這對於準確的診斷和治療計劃至關重要。
對營運模式的看法
從運作模式來看,市場有網路化、雲端基礎、現場化等特性。 2022 年,基於網路的區隔市場收益佔有率最高。網路為基礎的 CVIS 可以透過任何具有網路瀏覽器的網路連線裝置進行存取。這種彈性使醫療保健專業人員能夠從多個位置檢索患者資料和診斷資訊,從而促進遠端存取和遠端醫療。基於網路的 CVIS 不需要大量的現場基礎設施或硬體,從而降低了初始實施成本。這使得它具有成本效益,特別是對於小型醫療機構。
區域展望
從區域來看,本報告對北美、歐洲、亞太地區和拉丁美洲地區的市場進行了分析。 2022 年,北美市場佔市場最大收益佔有率。根據國家醫學圖書館的數據,經濟發展、文化習俗、遺傳傾向以及治療方法趨勢和風險因素的差異導致了北美地區心臟衰竭率的差異。美國和加拿大都是已開發國家,地理特徵、經濟和基礎建設體系、文化傳統相似。
The Global Cardiovascular Information System Market size is expected to reach $2.2 billion by 2030, rising at a market growth of 10.2% CAGR during the forecast period.
Over the forecast period, it is anticipated that the presence of quickly developing economies like China and India, where the healthcare system is rapidly improving, will accelerate the region's development. Thus, the Asia Pacific region would generate 25% share of the market by 2030. Due to a sharp rise in the number of patients, the region has seen a significant increase in healthcare spending, which has increased investments in R&D activities pertaining to cardiovascular diseases. Due to the development of novel and cutting-edge goods and technologies, the regional market has grown faster.
The major strategies followed by the market participants are Acquisitions as the key developmental strategy to keep pace with the changing demands of end users. For instance, In September, 2022, McKesson Corporation announced the acquisition of Rx Savings Solutions, to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements. Additionally, Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, to further build out its Learning Health Network consortium.
Based on the Analysis presented in the KBV Cardinal matrix; Cisco Systems, Inc. and Oracle Corporation are the forerunners in the Market. In July, 2021, Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., to enhance Cisco Webex's platform offerings and would provide customers with a better experience in online events. Companies such as Honeywell International, Inc., McKesson Corporation, Siemens Healthineers AG are some of the key innovators in the Market.
COVID-19 Impact Analysis
Healthcare facilities faced financial constraints due to the pandemic. Many resources were diverted to address COVID-19, impacting the allocation of funds for other healthcare technologies. As a result, some healthcare providers deferred investments in CVIS or other non-urgent systems. The pandemic disrupted regular operations in healthcare facilities. This led to delays in the implementation of new technologies, including CVIS. Therefore, the pandemic had a comparatively positive impact on the market. The adoption of CVIS has become a key component in healthcare, leading to positive growth in the market in the coming years.
Market Growth Factors
Increased efficiency and workflow optimization
The emphasis on efficiency in healthcare has led to the adoption of CVIS systems that streamline clinical workflows, reducing administrative burdens and enhancing the overall efficiency of patient care. The market has responded to this demand by providing specialized solutions that automate various tasks related to data retrieval, test interpretation, and report generation. This optimization directly impacts patient outcomes, as it enables quicker diagnosis and treatment, resulting in improved clinical efficacy and satisfaction for healthcare providers and patients alike. Data-driven medicine has fueled the demand for advanced CVIS solutions that can efficiently capture, store, and manage vast amounts of patient data and diagnostic information. Therefore, the increasing demand for CVIS solutions that enable efficient data management and workflow optimization underscores these systems' pivotal role in modern healthcare delivery.
Expansion of healthcare infrastructure
Rapid population growth, particularly in urban areas, increases healthcare infrastructure demands. In order to accommodate the increasing number of patients looking for medical care, facilities, and services must be expanded. As the global population ages, there is a greater need for healthcare services to address age-related health issues and provide long-term care. Expanding healthcare infrastructure often includes establishing new cardiology departments and cardiovascular care facilities. CVIS solutions are instrumental in providing a comprehensive platform for managing patient data and diagnostic information efficiently within these departments. The expansion of healthcare infrastructure has bolstered the growth and significance of the market by creating a demand for specialized solutions that support the efficient management of cardiovascular patient data and diagnostic information.
Market Restraining Factors
High implementation costs and complexity
The high implementation costs associated with CVIS present a major hindrance to many healthcare facilities. These costs encompass the purchase of hardware and software and expenses related to customization, integration with existing systems, and comprehensive staff training. For smaller healthcare organizations or those operating with limited budgets, these financial requirements can be prohibitive, discouraging the adoption of CVIS. As a result, many healthcare providers are unable to access the advanced data management and diagnostic capabilities offered by CVIS, leading to a digital divide in healthcare services. These challenges hinder the expansion of the market, limiting the potential benefits these systems can offer in terms of streamlined data management, enhanced diagnostic capabilities, and improved patient care.
Type Outlook
On the basis of type, the market is classified into CVIS and CPACS. The CPACS segment recorded a significant revenue share in the market in 2022. The cardiovascular picture archiving and communication system (CPACS) is designed to manage cardiovascular images, including echocardiograms, angiograms, and nuclear medicine scans. It provides a secure repository for these images, making them readily accessible to healthcare professionals. CPACS ensures the quality and consistency of cardiovascular images, including image format, resolution, and compression, which is critical for accurate diagnosis and treatment planning.
Mode Of Operation Outlook
Based on mode of operation, the market is characterized into web-based, cloud-based, and on-site. The web-based segment garnered the highest revenue share in the market in 2022. Web-based CVIS is accessible from any internet-connected device with a web browser. This flexibility allows healthcare professionals to retrieve patient data and diagnostic information from different locations, promoting remote access and telemedicine. The initial costs of implementing web-based CVIS can be lower because it doesn't require extensive on-site infrastructure and hardware. This can make it more cost-effective, particularly for smaller healthcare institutions.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the market in 2022. According to the National Library of Medicine, differences in economic development, cultural practices, genetic predisposition, and trends in treatments and risk factors contribute to variations in heart failure rates across North America. The US and Canada are industrialized countries with similar geographic characteristics, economic and infrastructure systems, and cultural traditions.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Cisco Systems, Inc., Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), Lumedx Corporation (Intelerad Medical Systems Incorporated), Agfa-Gevaert Group, Honeywell International, Inc., and McKesson Corporation
Strategies Deployed in Cardiovascular Information System Market
Mergers & Acquisition:
Feb-2023: GE HealthCare Technologies, Inc. signed an agreement to acquire Caption Health, Inc., a healthcare technology company specializing in artificial intelligence-driven ultrasound guidance to improve the quality and accessibility of medical imaging. Through this acquisition, GE HealthCare would be focused on performing fundamental echocardiogram assessments and making it possible to identify early signs of conditions such as heart failure in high-risk individuals.
Sep-2022: McKesson Corporation announced the acquisition of Rx Savings Solutions (RxSS), a healthcare technology company specializing in innovative prescription drug cost-saving solutions for both consumers and employers. Through this partnership, McKesson Corporation would be able to extend its biopharma services in prescription price transparency, catering to a broad spectrum of client requirements.
Jul-2021: Cisco Systems, Inc announced the acquisition of Socio Labs, Inc., an American event management platform provider. The acquisition enhances Cisco Webex's platform offerings and would provide customers with a better experience in online events.
Apr-2021: Siemens Healthineers AG acquired Varian Medical Systems, Inc., a global leader in cancer treatment solutions, providing advanced radiotherapy, radiosurgery, and brachytherapy technologies to improve the lives of cancer patients. Through this partnership, Siemens aimed to tackle the rising demand for personalized, data-informed diagnostics and precise cancer treatment, equipping us to combat the escalating global cancer epidemic.
Apr-2021: Cerner Corporation, a subsidiary of Oracle Corporation announced an agreement to acquire Kantar Health, a leading data, analytics, and real-world evidence and commercial research consultancy serving the life science industry, a division of Kantar Group. Through this acquisition, Cerner aimed to further build out its Learning Health Network consortium.
Feb-2021: Koninklijke Philips N.V. acquired BioTelemetry, Inc., a company that provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. Through this acquisition, Philips would be able to provide their clients with healthcare solutions with a primary focus on cardiac patients and other medical conditions, both within the hospital and in the comfort of their homes.
Aug-2020: Koninklijke Philips N.V. took over Intact Vascular, Inc., a medical device company focused on developing innovative solutions for the treatment of peripheral artery disease. Through this acquisition, Philips would be able to offer more solutions for Peripheral Artery Disease.
Product Launches:
Feb-2023: Honeywell International, Inc. introduced Spectra MG BIO fibers, a bio-based variation of Spectra fibres, known for their exceptional strength, durability, and lightweight properties, used in various applications including ballistic protection and industrial use.
Partnerships, Collaborations & Agreements:
Jul-2023: GE HealthCare Technologies, Inc., came into partnership with Elekta, a leader in radiation therapy, in the Indian market. Through this partnership, GE HealthCare would aim to facilitate greater efficiency, precision, and personalization throughout the entire cancer care journey, emphasizing our commitment to investing in solutions that enhance the quality of cancer care while making it more patient cantered.
Oct-2022: GE Healthcare came into collaboration, both companies would advance their efforts to streamline the oncology care process, focusing on enhanced data handling, pathology digitization, and simplified data retrieval.
Oct-2022: Siemens Healthineers AG came into partnership with iMedrix Systems Pvt Ltd., a healthcare technology company specializing in remote patient monitoring solutions and telemedicine services. Through this partnership, both companies would provide telecardiology technology to help their clients generate deeper insights into health.
Sep-2022: McKesson Corporation partnered with CVS Health, a diversified healthcare company that operates pharmacies, healthcare clinics, and health insurance services, focusing on improving access to quality healthcare and pharmaceuticals. Through this partnership, both companies would be able to fulfil the growing customer demands.
Jul-2020: Cerner Corporation, a subsidiary of Oracle Corporation came into partnership with Holon Solutions, a healthcare technology company focused on data integration and interoperability solutions to improve healthcare delivery and patient outcomes. Through this partnership, Cerner accelerated the development of, seamless clinical decision support at the point of care.
Oct-2019: LUMEDX, a subsidiary of Intelerad Medical Systems Incorporated, came into partnership with MedAxiom, a US-Based Business Consulting and Services company. Through this partnership, LUMEDX would aim to accelerate the enhancement of the HealthView Analytics (HVA) platform to provide better patient outcomes and significant cost savings.
Market Segments covered in the Report:
By Type
By Mode Of Operation
By Geography
Companies Profiled
Unique Offerings from KBV Research